BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18977464)

  • 21. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
    Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
    Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
    Smith TG; Talbot NP; Privat C; Rivera-Ch M; Nickol AH; Ratcliffe PJ; Dorrington KL; León-Velarde F; Robbins PA
    JAMA; 2009 Oct; 302(13):1444-50. PubMed ID: 19809026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary artery pressure in healthy subjects at 4250 m measured by Doppler echocardiography.
    Dubowitz G; Peacock AJ
    Wilderness Environ Med; 2007; 18(4):305-11. PubMed ID: 18076302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
    Cozzi F; Montisci R; Marotta H; Bobbo F; Durigon N; Ruscazio M; Sfriso P; Iliceto S; Todesco S
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():49-53. PubMed ID: 16919011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
    Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800 m.
    Stembridge M; Ainslie PN; Boulet LM; Anholm J; Subedi P; Tymko MM; Willie CK; Cooper SM; Shave R
    J Physiol; 2019 Feb; 597(4):1059-1072. PubMed ID: 29808473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?
    Schuuring MJ; Vis JC; Bouma BJ; van Dijk AP; van Melle JP; Pieper PG; Vliegen HW; Sieswerda GT; Mulder BJ
    Contemp Clin Trials; 2011 Jul; 32(4):586-91. PubMed ID: 21527360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altitude-Induced Pulmonary Hypertension on One-Day Rapid Ascent of Mount Fuji: Incidence and Therapeutic Effects of Sildenafil.
    Iwase M; Itou Y; Takada K; Shiino K; Kato Y; Ozaki Y
    Echocardiography; 2016 Jun; 33(6):838-43. PubMed ID: 26899426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary oedema.
    Steinacker JM; Tobias P; Menold E; Reissnecker S; Hohenhaus E; Liu Y; Lehmann M; Bärtsch P; Swenson ER
    Eur Respir J; 1998 Mar; 11(3):643-50. PubMed ID: 9596116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise limitation of acetazolamide at altitude (3459 m).
    Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
    Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
    Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
    Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension.
    Jing ZC; Strange G; Zhu XY; Zhou DX; Shen JY; Gu H; Yang ZK; Pan X; Xiang MX; Yao H; Zhao DB; Dalton BS; Zhang ZL; Wang Y; Cheng XS; Yang YJ
    J Heart Lung Transplant; 2010 Feb; 29(2):150-6. PubMed ID: 20113907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
    Gatzoulis MA; Beghetti M; Galiè N; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
    Int J Cardiol; 2008 Jun; 127(1):27-32. PubMed ID: 17658633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema.
    Eldridge MW; Podolsky A; Richardson RS; Johnson DH; Knight DR; Johnson EC; Hopkins SR; Michimata H; Grassi B; Feiner J; Kurdak SS; Bickler PE; Wagner PD; Severinghaus JW
    J Appl Physiol (1985); 1996 Aug; 81(2):911-21. PubMed ID: 8872663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary vascular reserve and exercise capacity at sea level and at high altitude.
    Pavelescu A; Faoro V; Guenard H; de Bisschop C; Martinot JB; Mélot C; Naeije R
    High Alt Med Biol; 2013 Mar; 14(1):19-26. PubMed ID: 23537256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m.
    Siebenmann C; Bloch KE; Lundby C; Nussbamer-Ochsner Y; Schoeb M; Maggiorini M
    High Alt Med Biol; 2011; 12(2):169-77. PubMed ID: 21718165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude.
    Jacobs KA; Kressler J; Stoutenberg M; Roos BA; Friedlander AL
    High Alt Med Biol; 2011; 12(3):215-22. PubMed ID: 21962064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of bosentan in adults with Eisenmenger physiology.
    Gatzoulis MA; Rogers P; Li W; Harries C; Cramer D; Ward S; Mikhail GW; Gibbs JS
    Int J Cardiol; 2005 Jan; 98(1):147-51. PubMed ID: 15676179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
    Guazzi M; Vicenzi M; Arena R
    Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome.
    Kaya MG; Lam YY; Erer B; Ayhan S; Vatankulu MA; Nurkalem Z; Meric M; Eren M; Eryol NK
    J Card Fail; 2012 May; 18(5):379-84. PubMed ID: 22555267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.